ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

RHA Annidis Corporation

0.00
0.00 (0.00%)
Last Updated: -
Delayed by 15 minutes
Share Name Share Symbol Market Type
Annidis Corporation TSXV:RHA TSX Venture Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

Annidis Corporation Announces Suspension and Reinstatement to Trading - Notice Transfer to NEX

17/05/2018 2:22pm

PR Newswire (Canada)


Annidis Corporation (TSXV:RHA)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Annidis Corporation Charts.

OTTAWA, May 17, 2018 /CNW/ - Annidis Corporation (TSX Venture: RHA) ("Annidis" or the "Corporation"), announces that it received the suspension and reinstatement to trading – notice transfer to NEX from TSX Venture Exchange.

The notice says, this will confirm that effective May 4, 2018; the TSX Venture Exchange (the "Exchange") suspended trading in the Company's securities as a result of a Cease Trade Order issued by the Ontario Securities Commission. A copy of the Exchange bulletin can be obtained from our website at tmx.com. Reinstatement to trading can occur only when the Cease Trade Order is revoked and the Exchange has concluded its reinstatement review to ensure the Company has satisfactorily complied with Exchange requirement.

About Annidis Corporation

Annidis (TSX-V: RHA) has developed, manufactures and sells a patented imaging platform technology based on multi-spectral imaging. The current RHA is a retinal screening technology used by primary care professionals for early disease detection. The RHA is complementary to diagnostic imaging technologies and supports the timely identification, treatment and monitoring of a wide range of vision threatening diseases.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Certain statements in this press release are forward looking statements and are prospective in nature, including statements with respect to the prospect of the Corporation finding a solution to its current financial situation or finding a potential strategic partner or investor. Forwardlooking statements are not based on historical facts, but rather on current expectations and projections about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forwardlooking statements. These statements generally can be identified by the use of forwardlooking words such as "may", "should", "will", "could", "intend", "estimate", "plan", "anticipate", "expect", "believe" or "continue", or the negative thereof or similar variations. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Such forwardlooking statements should therefore be construed in light of such factors, and the Corporation is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forwardlooking statements, whether as a result of new information, future events or otherwise.

SOURCE Annidis Corporation

Copyright 2018 Canada NewsWire

1 Year Annidis Corporation Chart

1 Year Annidis Corporation Chart

1 Month Annidis Corporation Chart

1 Month Annidis Corporation Chart

Your Recent History

Delayed Upgrade Clock